Govt slashes Remdesivir MRP by half, with retro-effect
Sat, Apr 17 2021 12:51 IST |
3 Views
Mumbai, April 17 : Spelling huge relief for lakhs of Covid-19 patients, the government has slashed the prices of the life-saver Remdesivir injection by nearly 50 per cent, to MRP Rs 2,450 per injection now, according to official sources.
In a missive late on Friday, the Ministry of Chemicals & Fertilisers, Department of Pharmaceuticals, NPPA - Advisor (Costs) N.I. Chowdhury has ordered all pharma companies to comply with the revised norms with immediate and retrospective effect. Based on the Form-V furnished regarding voluntary reduction in Maximum Retail Price (MRP) of Remdesivir, Manufacturers/Marketers of the Remdesivir are hereby directed to implement the revised MRP throughout the distribution chain w.e.f. 15.04.2021, irrespective of the batch numbers, the stern notification said.
Spelling huge relief for lakhs of Covid-19 patients, the government has slashed the prices of the life-saver Remdesivir injection by nearly 50 per cent, to MRP Rs 2,450 per injection now, according to official sources. In a missive late on Friday, the Ministry of Chemicals & Fertilisers, Department of Pharmaceuticals, NPPA - Advisor (Costs) N.I. Chowdhury has ordered all pharma companies to comply with the revised norms with immediate and retrospective effect. Based on the Form-V furnished regarding voluntary reduction in Maximum Retail Price (MRP) of Remdesivir, Manufacturers/Marketers of the Remdesivir are hereby directed to implement the revised MRP throughout the distribution chain w.e.f. 15.04.2021, irrespective of the batch numbers, the stern notification said.
Government slashes Remdesivir MRP by half, with retro-effect indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Maharshtra to face shortage of Remdesivir for next 2 to 3 days: Minister
State FDA Minister Rajendra Shingane said pharma companies manufacturing Remdesivir have stepped up production but it will take time for the new stock to reach market.
Share Via Email
| A+A A- By PTI
MUMBAI: Maharashtra will face a shortage of 12,000 to 15,000 Remdesivir injections, used to treat COVID-19 patients, for the next two to three days, state Food and Drug Administration (FDA) Minister Rajendra Shingane said on Friday.
He said pharma companies manufacturing Remdesivir have stepped up production but it will take time for the new stock to reach the market.